Sunday 19 November 2017
Contact US    |    Archive
PR
3 months ago

Uptake of Sanofi/Regeneron s Dupixent for Atopic Dermatitis Strong, but Sales Representative Contact Rates Leave Something to be Desired

EXTON, Pa., Aug. 21, 2017 /PRNewswire/ -- According to the Q3 update of RealTime Dynamix™: Atopic De

Read on the original site


Hashtags:   

Uptake

 | 

Sanofi

 | 

Regeneron

 | 

Dupixent

 | 

for

 | 

Atopic

 | 

Dermatitis

 | 

Strong

 | 

but

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Categories - Countries
All News
All Countries